Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients

Fig. 4

FOXA1 mRNA expression in: a. NT - Normal Tissue; b. ER+/AR+ tumors; c. ER+/AR- tumors; d. ER−/AR+ tumors; e. ER−/AR- tumors. Independently of ER status, FOXA1 mRNA levels were higher (low delta-Ct) in AR+ tumors, compared to AR- cases. Tukey’s multiple comparisons test showed significant differences, mainly, between groups with AR+ and AR- cases (p < 0.0001. Additional file 1: Table S4). *ANOVA analysis

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us